Moderna CCO granted RSUs and stock options
Moderna, Inc. reported that Chief Commercial Officer Banque Soria Ester received new equity awards as part of compensation.
Rhea-AI Filing Summary
Moderna, Inc. reported that Chief Commercial Officer Banque Soria Ester received new equity awards as part of compensation. She was granted 38,364 restricted stock units, each convertible into one share of common stock. She was also granted 18,658 stock options with an exercise price of $79.76 per share.
For both awards, 25% are scheduled to vest on July 5, 2027, with the remaining portions vesting in twelve equal quarterly installments after that date. These are awards from the company and do not involve any open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 57,022 shares
Grant/Award
2 txns
Insider
Banque Soria Ester
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 18,658 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 38,364 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 18,658 contracts (Direct);
Restricted Stock Units — 38,364 contracts (Direct)
Footnotes (3)
- F1. 25% of this option will vest and become exercisable on July 5, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- F2. Restricted stock units convert into common stock on a one-for-one basis.
- F3. 25% of the shares subject to this restricted stock unit award will vest on July 5, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
Key Figures
RSU grant size: 38,364 units
Stock option grant size: 18,658 options
Option exercise price: $79.76 per share
+4 more
7 metrics
RSU grant size
38,364 units
Restricted stock units granted to CCO, one-for-one into common stock
Stock option grant size
18,658 options
New stock options granted to CCO
Option exercise price
$79.76 per share
Conversion or exercise price for stock options
RSU vesting start
July 5, 2027
25% of RSU award vests on this date
Option vesting start
July 5, 2027
25% of options vest and become exercisable on this date
Remaining vesting pattern
12 quarterly installments
Remaining 75% of both RSUs and options vest quarterly
Option expiration
July 5, 2036
Expiration date of the granted stock options
Key Terms
Restricted Stock Units, Stock Option (Right to Buy), exercise price, vest, +1 more
5 terms
Restricted Stock Units financial
"security_title: Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 79.7600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"25% of this option will vest and become exercisable on July 5, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
quarterly installments financial
"remainder vesting in twelve (12) equal quarterly installments thereafter"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Moderna (MRNA) grant to its Chief Commercial Officer?
Moderna granted its Chief Commercial Officer 38,364 restricted stock units and 18,658 stock options. The options have an exercise price of $79.76 per share, and both awards follow a multi-year vesting schedule beginning in July 2027.
What is the vesting schedule for the new Moderna (MRNA) equity awards?
Both the RSUs and options vest with 25% on July 5, 2027. The remaining 75% of each award then vests in twelve equal quarterly installments, spreading vesting over several years to encourage longer-term retention.
What is the exercise price of the new Moderna (MRNA) stock options?
The newly granted stock options have an exercise price of $79.76 per share. This means the executive can buy Moderna common stock at $79.76 per share once the options vest and are exercisable, subject to the award’s terms.
How many Moderna (MRNA) restricted stock units now belong to the Chief Commercial Officer?
After this transaction, the Chief Commercial Officer holds 38,364 restricted stock units. Each unit represents the right to receive one share of Moderna common stock when it vests and settles, following the defined vesting schedule.
When do the newly granted Moderna (MRNA) stock options expire?
The newly granted stock options are scheduled to expire on July 5, 2036. The options vest over time starting in 2027, and any unexercised options would lapse after the stated expiration date if not exercised earlier.
AI-generated analysis. How Rhea-AI works. Not financial advice.
